NCT03175432 2026-04-15Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain MetastasesM.D. Anderson Cancer CenterPhase 2 Active not recruiting29 enrolled
NCT04835805 2026-03-30A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.Genentech, Inc.Phase 1 Active not recruiting65 enrolled